Company / Working Capital
Immunome Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$615.8M
FY2025
5-year range
$15.3M / $615.8M
FY2021-FY2025
Trend
+268.7%
vs FY2024
Sector context
#74 of 213
Health Care
What the data says
Working Capital changed +269% YoY in FY2025, a notable deviation from the 6-year average annual change of +599%.
Based on SEC 10-K filings.
$616M in FY2025 with a 5-year CAGR of +72.9%.
Improved from $123M to $616M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +242.6%
- 5-Year CAGR
- +72.9%
- 10-Year CAGR
- -
Sector benchmark
#74 of 213 in Health CareTop 35% of 213This company $615.8M Sector average $934.6M
▼
-34.1% below sector average
Key checks
Key Insights
- Immunome Inc.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of +72.9%, indicating consistent growth.
- In FY2025, working capital increased 268.7% year-over-year.
- Ranks #74 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $615.8M | +268.7% |
| FY2024 | $167.0M | +35.9% |
| FY2023 | $122.9M | +702.2% |
| FY2022 | $15.3M | -67.3% |
| FY2021 | $46.9M | +17.7% |
| FY2020 | $39.9M | +2635.5% |
| FY2019 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026